Objective GTP cyclohydrolase I (GCH1) is the rate-limiting enzyme for tetrahydrobiopterin biosynthesis and has been shown to be a promising therapeutic target in ischemic heart disease, hypertension, atherosclerosis and diabetes. The endogenous GCH1-interacting partners have not been identified. Here, we determined endogenous GCH1-interacting proteins in rat. Methods and Results A pulldown and proteomics approach were used to identify GCH1 interacting proteins in rat liver, brain, heart and kidney. We demonstrated that GCH1 interacts with at least 17 proteins including GTP cyclohydrolase I feedback regulatory protein (GFRP) in rat liver by affinity purification followed by proteomics and validated six protein partners in liver, brain, heart and kidney by immunoblotting. GCH1 interacts with GFRP and very long-chain specific acyl-CoA dehydrogenase in the liver, tubulin beta-2A chain in the liver and brain, DnaJ homolog subfamily A member 1 and fatty aldehyde dehydrogenase in the liver, heart and kidney and eukaryotic translation initiation factor 3 subunit I (EIF3I) in all organs tested. Furthermore, GCH1 associates with mitochondrial proteins and GCH1 itself locates in mitochondria. Conclusion GCH1 interacts with proteins in an organ dependant manner and EIF3I might be a general regulator of GCH1. Our finding indicates GCH1 might have broader functions beyond tetrahydrobiopterin biosynthesis.
References
[1]
Thony B, Auerbach G, Blau N (2000) Tetrahydrobiopterin biosynthesis, regeneration and functions. Biochem J 347 Pt 1: 1–16.
[2]
Moens AL, Kass DA (2007) Therapeutic potential of tetrahydrobiopterin for treating vascular and cardiac disease. J Cardiovasc Pharmacol 50: 238–246.
[3]
Werner-Felmayer G, Golderer G, Werner ER (2002) Tetrahydrobiopterin biosynthesis, utilization and pharmacological effects. Curr Drug Metab 3: 159–173.
[4]
Muller U, Steinberger D, Topka H (2002) Mutations of GCH1 in Dopa-responsive dystonia. J Neural Transm 109: 321–328.
[5]
Gunasekera RS, Hyland K (2009) In vivo regulation of phenylalanine hydroxylase in the genetic mutant hph-1 mouse model. Mol Genet Metab 98: 264–272.
[6]
Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, et al. (2006) GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med 12: 1269–1277.
[7]
Campbell CM, Edwards RR, Carmona C, Uhart M, Wand G, et al. (2009) Polymorphisms in the GTP cyclohydrolase gene (GCH1) are associated with ratings of capsaicin pain. Pain 141: 114–118.
[8]
An J, Du J, Wei N, Xu H, Pritchard KA Jr, et al. (2009) Role of tetrahydrobiopterin in resistance to myocardial ischemia in Brown Norway and Dahl S rats. Am J Physiol Heart Circ Physiol 297: H1783–1791.
[9]
Ge ZD, Ionova IA, Vladic N, Pravdic D, Hirata N, et al. (2011) Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia. Cardiovasc Res 91: 340–349.
[10]
Ionova IA, Vasquez-Vivar J, Cooley BC, Khanna AK, Whitsett J, et al. (2010) Cardiac myocyte-specific overexpression of human GTP cyclohydrolase I protects against acute cardiac allograft rejection. Am J Physiol Heart Circ Physiol 299: H88–96.
[11]
Du YH, Guan YY, Alp NJ, Channon KM, Chen AF (2008) Endothelium-specific GTP cyclohydrolase I overexpression attenuates blood pressure progression in salt-sensitive low-renin hypertension. Circulation 117: 1045–1054.
[12]
Alp NJ, McAteer MA, Khoo J, Choudhury RP, Channon KM (2004) Increased endothelial tetrahydrobiopterin synthesis by targeted transgenic GTP-cyclohydrolase I overexpression reduces endothelial dysfunction and atherosclerosis in ApoE-knockout mice. Arterioscler Thromb Vasc Biol 24: 445–450.
[13]
Milstien S, Jaffe H, Kowlessur D, Bonner TI (1996) Purification and cloning of the GTP cyclohydrolase I feedback regulatory protein, GFRP. J Biol Chem 271: 19743–19751.
[14]
Yoneyama T, Hatakeyama K (1998) Decameric GTP cyclohydrolase I forms complexes with two pentameric GTP cyclohydrolase I feedback regulatory proteins in the presence of phenylalanine or of a combination of tetrahydrobiopterin and GTP. J Biol Chem 273: 20102–20108.
[15]
Higgins CE, Gross SS (2010) The N-terminal peptide of mammalian GTP cyclohydrolase I is an autoinhibitory control element and contributes to binding the allosteric regulatory protein GFRP. J Biol Chem 286: 11919–11928.
[16]
Li L, Rezvan A, Salerno JC, Husain A, Kwon K, et al. (2009) GTP cyclohydrolase I phosphorylation and interaction with GTP cyclohydrolase feedback regulatory protein provide novel regulation of endothelial tetrahydrobiopterin and nitric oxide. Circ Res 106: 328–336.
[17]
Funderburk CD, Bowling KM, Xu D, Huang Z, O'Donnell JM (2006) A typical N-terminal extensions confer novel regulatory properties on GTP cyclohydrolase isoforms in Drosophila melanogaster. J Biol Chem 281: 33302–33312.
[18]
Tatham AL, Crabtree MJ, Warrick N, Cai S, Alp NJ, et al. (2009) GTP cyclohydrolase I expression, protein, and activity determine intracellular tetrahydrobiopterin levels, independent of GTP cyclohydrolase feedback regulatory protein expression. J Biol Chem 284: 13660–13668.
[19]
Du J, Xu H, Wei N, Wakim B, Halligan B, et al. (2009) Identification of proteins interacting with GTP cyclohydrolase I. Biochem Biophys Res Commun 385: 143–147.
[20]
Swick L, Kapatos G (2006) A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions. J Neurochem 97: 1447–1455.
[21]
Bowling KM, Huang Z, Xu D, Ferdousy F, Funderburk CD, et al. (2008) Direct binding of GTP cyclohydrolase and tyrosine hydroxylase: regulatory interactions between key enzymes in dopamine biosynthesis. J Biol Chem 283: 31449–31459.
[22]
Peterson TE, d'Uscio LV, Cao S, Wang X-L, Katusic ZS (2009) Guanosine Triphosphate Cyclohydrolase I Expression and Enzymatic Activity Are Present in Caveolae of Endothelial Cells. Hypertension 53: 189–195.
[23]
Du J, Wei N, Xu H, Ge Y, Vasquez-Vivar J, et al. (2009) Identification and functional characterization of phosphorylation sites on GTP cyclohydrolase I. Arterioscler Thromb Vasc Biol 29: 2161–2168.
[24]
Frezza C, Cipolat S, Scorrano L (2007) Organelle isolation: functional mitochondria from mouse liver, muscle and cultured fibroblasts. Nat Protoc 2: 287–295.
[25]
Imazumi K, Sasaki T, Takahashi K, Takai Y (1994) Identification of a rabphilin-3A-interacting protein as GTP cyclohydrolase I in PC12 cells. Biochem Biophys Res Commun 205: 1409–1416.
[26]
Widder JD, Chen W, Li L, Dikalov S, Thony B, et al. (2007) Regulation of tetrahydrobiopterin biosynthesis by shear stress. Circ Res 101: 830–838.
[27]
Xu J, Wu Y, Song P, Zhang M, Wang S, et al. (2007) Proteasome-dependent degradation of guanosine 5′-triphosphate cyclohydrolase I causes tetrahydrobiopterin deficiency in diabetes mellitus. Circulation 116: 944–953.
[28]
Togari A, Ichinose H, Matsumoto S, Fujita K, Nagatsu T (1992) Multiple mRNA forms of human GTP cyclohydrolase I. Biochem Biophys Res Commun 187: 359–365.
[29]
Golderer G, Werner ER, Heufler C, Strohmaier W, Grobner P, et al. (2001) GTP cyclohydrolase I mRNA: novel splice variants in the slime mould Physarum polycephalum and in human monocytes (THP-1) indicate conservation of mRNA processing. Biochem J 355: 499–507.
[30]
Gutlich M, Schott K, Werner T, Bacher A, Ziegler I (1992) Species and tissue specificity of mammalian GTP cyclohydrolase I messenger RNA. Biochim Biophys Acta 1171: 133–140.
[31]
Hinnebusch AG (2006) eIF3: a versatile scaffold for translation initiation complexes. Trends Biochem Sci 31: 553–562.
[32]
Sha Z, Brill LM, Cabrera R, Kleifeld O, Scheliga JS, et al. (2009) The eIF3 interactome reveals the translasome, a supercomplex linking protein synthesis and degradation machineries. Mol Cell 36: 141–152.
[33]
Chen RH, Miettinen PJ, Maruoka EM, Choy L, Derynck R (1995) A WD-domain protein that is associated with and phosphorylated by the type II TGF-beta receptor. Nature 377: 548–552.
[34]
Perez RE, Navarro A, Rezaiekhaligh MH, Mabry SM, Ekekezie (2011) TRIP-1 regulates TGF-{beta}1-induced epithelial-mesenchymal transition of human lung epithelial cell line A549. Am J Physiol Lung Cell Mol Physiol 300: L799–807.
[35]
Choy L, Derynck R (1998) The type II transforming growth factor (TGF)-beta receptor-interacting protein TRIP-1 acts as a modulator of the TGF-beta response. J Biol Chem 273: 31455–31462.
[36]
Tie L, Li XJ, Wang X, Channon KM, Chen AF (2009) Endothelium-specific GTP cyclohydrolase I overexpression accelerates refractory wound healing by suppressing oxidative stress in diabetes. Am J Physiol Endocrinol Metab 296: E1423–1429.
[37]
Delgado-Esteban M, Almeida A, Medina JM (2002) Tetrahydrobiopterin deficiency increases neuronal vulnerability to hypoxia. J Neurochem 82: 1148–1159.
[38]
Ceylan-Isik AF, Guo KK, Carlson EC, Privratsky JR, Liao SJ, et al. (2009) Metallothionein abrogates GTP cyclohydrolase I inhibition-induced cardiac contractile and morphological defects: role of mitochondrial biogenesis. Hypertension 53: 1023–1031.
[39]
Ge ZD, Ionova IA, Vladic N, Pravdic D, Hirata N, et al. (2011) Cardiac-specific overexpression of GTP cyclohydrolase 1 restores ischaemic preconditioning during hyperglycaemia. Cardiovasc Res.
[40]
Finocchietto PV, Franco MC, Holod S, Gonzalez AS, Converso DP, et al. (2009) Mitochondrial nitric oxide synthase: a masterpiece of metabolic adaptation, cell growth, transformation, and death. Exp Biol Med (Maywood) 234: 1020–1028.
[41]
Kabuyama Y, Suzuki T, Nakazawa N, Yamaki J, Homma MK, et al. (2009) Dysregulation of very long chain acyl-CoA dehydrogenase coupled with lipid peroxidation. Am J Physiol Cell Physiol 298: C107–113.
